Phosphate binder: Difference between revisions
CSV import |
No edit summary Tag: Manual revert |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 39: | Line 39: | ||
[[Category:Chronic kidney disease]] | [[Category:Chronic kidney disease]] | ||
[[Category:Hyperphosphatemia]] | [[Category:Hyperphosphatemia]] | ||
{{No image}} | |||
Latest revision as of 18:42, 18 March 2025
Phosphate binders are medications used to reduce the absorption of dietary phosphate; they are taken along with meals and snacks. They are frequently used in patients with chronic kidney disease (CKD) where they are used to treat hyperphosphatemia, a condition where there is an abnormally elevated level of phosphate in the blood.
Mechanism of Action[edit]
Phosphate binders work by binding to the phosphate in the gastrointestinal tract, thereby reducing its absorption into the body. This helps to maintain a balance of phosphate, which is important for bone health and the function of cells.
Types of Phosphate Binders[edit]
There are several types of phosphate binders, including:
- Calcium-based binders: These include calcium carbonate and calcium acetate.
- Non-calcium-based binders: These include sevelamer hydrochloride, lanthanum carbonate, and sucroferric oxyhydroxide.
- Iron-based binders: These include ferric citrate and sucroferric oxyhydroxide.
Side Effects[edit]
Like all medications, phosphate binders can have side effects. These can include:
Patients should always discuss potential side effects with their healthcare provider before starting a new medication.
See Also[edit]
References[edit]
<references />


